Genetic key to why some lymphoma patients don’t respond to treatment
An important regulator that controls the ability of tumour cells to hide from the immune system in lymphoma patients, making them unlikely to respond to standard treatment, has been discovered by scientists at the University of Oxford. Researchers analysed tumour samples from individual patients with diffuse large B-cell lymphoma (DLBCL), alongside cell line models and […]
